Tetracycline and penicillin resistant Clostridium perfringens isolated from the fangs and venom glands of Loxosceles laeta: its implications in loxoscelism treatment.

[1]  J. C. Ríos,et al.  [Prevalence and epidemiology of Loxosceles laeta bite. Analysis of consultations to a poison control center]. , 2007, Revista medica de Chile.

[2]  D. Tambourgi,et al.  Tetracycline protects against dermonecrosis induced by Loxosceles spider venom. , 2007, The Journal of investigative dermatology.

[3]  S. J. Billington,et al.  Skewed genomic variability in strains of the toxigenic bacterial pathogen, Clostridium perfringens. , 2006, Genome research.

[4]  D. Hecht.  Anaerobes: antibiotic resistance, clinical significance, and the role of susceptibility testing. , 2006, Anaerobe.

[5]  K. Winkel,et al.  Loxoscelism: old obstacles, new directions. , 2004, Annals of emergency medicine.

[6]  S. S. Veiga,et al.  Brown spiders and loxoscelism. , 2004, Toxicon : official journal of the International Society on Toxinology.

[7]  C. Greko,et al.  Antimicrobial susceptibility of Swedish, Norwegian and Danish isolates of Clostridium perfringens from poultry, and distribution of tetracycline resistance genes. , 2004, Veterinary microbiology.

[8]  F. HugoSchenone.  Cuadros tóxicos producidos por mordeduras de araña en Chile: latrodectismo y loxoscelismo , 2003 .

[9]  S. S. Veiga,et al.  Isolation and identification of Clostridium perfringens in the venom and fangs of Loxosceles intermedia (brown spider): enhancement of the dermonecrotic lesion in loxoscelism. , 2002, Toxicon : official journal of the International Society on Toxinology.

[10]  J. Rood,et al.  Transcriptional Analysis of thetet(P) Operon from Clostridium perfringens , 2001, Journal of bacteriology.

[11]  Y. Tamura,et al.  Tetracycline-resistance genes of Clostridium perfringens, Clostridium septicum and Clostridium sordellii isolated from cattle affected with malignant edema. , 2001, Veterinary microbiology.

[12]  F. H. Schenone,et al.  Loxoscelismo en pediatría: Región Metropolitana, Chile , 2001 .

[13]  H. Vlamakis,et al.  Evidence for Extensive Resistance Gene Transfer amongBacteroides spp. and among Bacteroides and Other Genera in the Human Colon , 2001, Applied and Environmental Microbiology.

[14]  J. Songer,et al.  Bacterial phospholipases and their role in virulence. , 1997, Trends in microbiology.

[15]  J. Rood,et al.  Genetic organization and distribution of tetracycline resistance determinants in Clostridium perfringens , 1996, Antimicrobial agents and chemotherapy.

[16]  E. Goldstein,et al.  Identification and antimicrobial resistance patterns of clinical isolates of Clostridium clostridioforme, Clostridium innocuum, and Clostridium ramosum compared with those of clinical isolates of Clostridium perfringens , 1995, Journal of clinical microbiology.

[17]  S. Cole,et al.  Molecular genetics and pathogenesis of Clostridium perfringens , 1991, Microbiological reviews.

[18]  K. Phillips,et al.  Antibiotic susceptibility of clinical isolates of clostridia. , 1985, The Journal of antimicrobial chemotherapy.

[19]  J L Middlebrook,et al.  Bacterial toxins: cellular mechanisms of action , 1984, Microbiological reviews.

[20]  R. Williamson.  Resistance of Clostridium perfringens to beta-lactam antibiotics mediated by a decreased affinity of a single essential penicillin-binding protein. , 1983, Journal of general microbiology.

[21]  M. Barza,et al.  Penicillin-binding proteins in Clostridium perfringens , 1981, Antimicrobial Agents and Chemotherapy.

[22]  L. Devriese,et al.  Macrolide-lincosamide-streptogramin resistance patterns in Clostridium perfringens from animals , 1981, Antimicrobial Agents and Chemotherapy.

[23]  J. McDonel.  Clostridium perfringens toxins (type A, B, C, D, E). , 1980, Pharmacology & therapeutics.

[24]  L. Smith,et al.  Virulence factors of Clostridium perfringens. , 1979, Reviews of infectious diseases.

[25]  J. Rood,et al.  Identification of a transferable tetracycline resistance plasmid (pCW3) from Clostridium perfringens. , 1978, Plasmid.

[26]  E. Maher,et al.  Isolation and Characterization of Multiply Antibiotic-Resistant Clostridium perfringens Strains from Porcine Feces , 1978, Antimicrobial Agents and Chemotherapy.

[27]  J. Schwartzman,et al.  Susceptibility of Clostridium perfringens Isolated from Human Infections to Twenty Antibiotics , 1977, Antimicrobial Agents and Chemotherapy.

[28]  Ellen Jo Baron,et al.  Manual of clinical microbiology , 1975 .

[29]  R. Perkins,et al.  Microdilution Technique for Antimicrobial Susceptibility Testing of Anaerobic Bacteria , 1975, Antimicrobial Agents and Chemotherapy.

[30]  C. Nord,et al.  Antibiotic susceptibility of Clostridium species isolated from human infections. , 1975, Scandinavian journal of infectious diseases.

[31]  W. Bucherl.  Biology and venoms of the most important South American spiders of the genera Phoneutria, Loxosceles, Lycosa, and Latrodectus. , 1969, American zoologist.

[32]  A. Burgen,et al.  The action of botulinum toxin on the neuro‐muscular junction , 1949, The Journal of physiology.